Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2

被引:48
|
作者
Catusse, J [1 ]
Liotard, A [1 ]
Loillier, B [1 ]
Pruneau, D [1 ]
Paquet, JL [1 ]
机构
[1] Lab Fournier SA, Grp Pharmacochim Recepteurs, F-21121 Daix, France
关键词
G protein-coupled receptor; binding; activation; CXCL8; CXCL1; SB; 225002;
D O I
10.1016/S0006-2952(02)01619-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neutrophil recruitment to inflammatory sites is mediated by two related receptors: CXC chemokine receptors I (CXCR1) and 2 (CXCR2). Both receptors share two ligands, interleukin-8 (CXCL8) and GCP-2 (CXCL6), whereas several chemokines, including growth related oncogen alpha (CXCL 1) and a non-peptide antagonist (SB 225002) are specific for CXCR2. The objective of this study was to map the different amino acids involved in the binding and activation/inhibition of human CXCR2. This was performed by exchanging non-conserved amino acids of CXCR2 with their counterparts in CXCR1. The mutants generated showed that: (a) for CXCL8 binding, the N-terminus of CXCR1 and the second extra-cellular loop of CXCR2 are determinant, the N-terminus of CXCR2 is not sufficient and the transmembrane domain seven is probably involved; (b) for CXCL1, the N-terminus of CXCR2 is necessary but not Sufficient for binding. The activation study indicated that amino acids critical for activation are not necessarily involved in binding process. Finally, the mechanism of binding of a non-peptide antagonist on CXCR2 was investigated: it Occurred through epitopes (a) which were disseminated within the receptor, (b) which differed according to the use of CXCL8 or CXCL1 as a competitor and (c) which did not necessarily overlap with agonist binding sites. We also showed that inhibition of binding and inhibition of activation involved different amino acids. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:813 / 821
页数:9
相关论文
共 34 条
  • [21] The selective CXCR2 antagonist SB272844 blocks interleukin-8 and growth-related oncogene-α-mediated inhibition of spontaneous neutrophil apoptosis
    Glynn, PC
    Henney, E
    Hall, IP
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2002, 15 (02) : 103 - 110
  • [22] Modulation of MMP9 and CXCR2/CXCL1/IL-8 axis in human abdominal aortic aneurysm tissues by ladarixin
    Lombardi, Maria
    Spartano, Lucia
    Nicolo, Sabrina
    Ardita, Vincenzo
    Chiesa, Roberto
    Aramini, Andrea
    Allegretti, Marcello
    Baccellieri, Domenico
    De Filippis, Lidia
    Foglieni, Chiara
    CARDIOVASCULAR RESEARCH, 2024, 120 (15) : 1832 - 1834
  • [23] Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer
    Pold, M
    Zhu, LX
    Sharma, S
    Burdick, MD
    Lin, Y
    Lee, PPN
    Pold, A
    Luo, J
    Krysan, K
    Dohadwala, M
    Mao, JT
    Batra, RK
    Strieter, RM
    Dubinett, SM
    CANCER RESEARCH, 2004, 64 (05) : 1853 - 1860
  • [24] Interleukin-17-and protease-activated receptor 2-mediated production of CXCL1 and CXCL8 modulated by cyclosporine A, vitamin D3 and glucocorticoids in human keratinocytes
    Takei-Taniguchi, Ryoko
    Imai, Yasutomo
    Ishikawa, Chika
    Sakaguchi, Yoshiko
    Nakagawa, Noboru
    Tsuda, Tatsuya
    Hollenberg, Morley D.
    Yamanishi, Kiyofumi
    JOURNAL OF DERMATOLOGY, 2012, 39 (07): : 625 - 631
  • [25] Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8 CXCL8 in human rheumatoid synovial fibroblasts
    Cho, Mi-La
    Ju, Ji-Hyeon
    Kim, Hae-Rim
    Oh, Hye-Joa
    Kang, Chang-Min
    Jhun, Joo-Yeon
    Lee, Seon-Yeong
    Park, Mi-Kyung
    Min, Jun-Ki
    Park, Sung-Hwan
    Lee, Sang-Heon
    Kim, Ho-Youn
    IMMUNOLOGY LETTERS, 2007, 108 (02) : 121 - 128
  • [26] Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils
    De Buck, Mieke
    Berghmans, Nele
    Portner, Noemie
    Vanbrabant, Lotte
    Cockx, Maaike
    Struyf, Sofie
    Opdenakker, Ghislain
    Proost, Paul
    Van Damme, Jo
    Gouwy, Mieke
    JOURNAL OF LEUKOCYTE BIOLOGY, 2015, 98 (06) : 1049 - 1060
  • [27] Towards in situ tissue repair: Human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2. and migrate upon stimulation with CXCL8 but not CCL2
    Ringe, Jochen
    Strassburg, Sandra
    Neumann, Katja
    Endres, Michaela
    Notter, Michael
    Burmester, Gerd-Ruediger
    Kaps, Christian
    Sittinger, Michael
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 101 (01) : 135 - 146
  • [28] CXCR1/CXCR2 Antagonist CXCL8(3-74)K11R/G31P Blocks Lung Inflammation In Swine Barn Dust-Instilled Mice
    Wyatt, T. A.
    Gordon, J. R.
    DeVasure, J. M.
    Heires, A. J.
    Canady, K. J.
    Romberger, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [29] CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks lung inflammation in swine barn dust-instilled mice
    Schneberger, D.
    Gordon, J. R.
    DeVasure, J. M.
    Boten, J. A.
    Heires, A. J.
    Romberger, D. J.
    Wyatt, T. A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 31 : 55 - 62
  • [30] The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31 P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals
    Gordon, JR
    Li, F
    Zhang, XB
    Wang, WJ
    Zhao, XX
    Nayyar, A
    JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 78 (06) : 1265 - 1272